Evolent Health
EVH
215 hedge funds and large institutions have $2.7B invested in Evolent Health in 2022 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 78 reducing their positions, and 30 closing their positions.
43% more funds holding in top 10
Funds holding in top 10: 7 → 10 (+3)
2.68% more ownership
Funds ownership: 95.26% → 97.94% (+2.7%)
3% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 30
1% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 78
3% less capital invested
Capital invested by funds: $2.78B → $2.7B (-$76.9M)
1% less funds holding
Funds holding: 218 → 215 (-3)
15% less call options, than puts
Call options by funds: $5.27M | Put options by funds: $6.19M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.4M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$23.7M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$20.5M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$19M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$39.2M |
| 2 |
EC
Engaged Capital
Newport Beach,
California
|
-$28.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$21.5M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$17.3M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$15.1M |
EVH Hedge Fund Activity: Q2 2022 in Review
215 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2022, worth a combined $2.7B — down 2.8% from $2.78B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new EVH positions and 30 closed out — a net gain of 1 holder — while 77 added to existing stakes and 78 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $31.4M. The largest seller was Granahan Investment Management, cutting an estimated $39.2M.
- 215 institutional investors held Evolent Health (EVH) as of Q2 2022, down from 218 in Q1 2022.
- Funds reported $2.7B of Evolent Health stock for Q2 2022, down 2.8% quarter-over-quarter.
- 31 funds opened new Evolent Health positions in Q2 2022 and 30 closed out, a net change of +1 holder.
- The largest Evolent Health buyer in Q2 2022 was Fidelity Investments, an estimated $31.4M added.
- The largest Evolent Health seller in Q2 2022 was Granahan Investment Management, an estimated $39.2M sold.
Based on aggregated 13F filings for Q2 2022.